SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (297)11/1/2000 6:21:29 PM
From: sim1  Read Replies (2) of 2243
 
OK, I'll stick my neck out. My personal choice is a recent IPO called Atherogenics (AGIX). I don't know if this could be a 100 bagger or not but its prospects seem to me to be quite promising.

Their focus is drug discovery for treating diseases of chronic inflamation which include atherosclerosis, coronary artery disease, asthma, rheumatoid arthritis,..., what appear to me to be huge unmet needs.

They licensed their lead compound AGI-1067 to SGP for the treatment and prevention of restenosis about a year ago where SGP will pay AGIX some $189m in potential milestone payments + royalties for "exclusive worldwide rights to develop, manufacture and market AGI-1067 and additional library of AtheroGenics vascular protectant compounds." According to their web site, they expect to complete a Phase II clinical trial of AGI-1067 the first half of 2001 after successfully completing seven Phase I clinical trials comprising more than 150 men and women.

Taking SGP's DD on faith gave me the confidence to establish a position early last week.

As always, this particular pick could also go to $0.

This one as well. So far though, I'm feeling pretty smart:-).



Here's the SGP press release on the license agreement.
schering-plough.com


and the AGIX web site.
atherogenics.com

I let my instincts guide me on this one. As far as what Rick might have in mind, I haven't a clue.

Stuart
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext